{"id":3031,"date":"2022-11-10T07:53:52","date_gmt":"2022-11-10T07:53:52","guid":{"rendered":"https:\/\/www.magna.org\/fr\/?p=3031"},"modified":"2022-12-02T21:40:25","modified_gmt":"2022-12-02T21:40:25","slug":"hiv-aids","status":"publish","type":"post","link":"https:\/\/www.magna.org\/fr\/sk\/zdravotne-aktivity\/hiv-aids\/","title":{"rendered":"HIV\/AIDS"},"content":{"rendered":"
\n

Bez lie\u010dby umiera polovica nakazen\u00fdch det\u00ed e\u0161te pred svojimi druh\u00fdmi narodeninami.<\/h2>\n<\/div><\/div>\n\n
\n

Na konci roka 2017 \u017eilo pribli\u017ene 36,9 mili\u00f3na \u013eud\u00ed s v\u00edrusom naru\u0161uj\u00facim \u013eudsk\u00fa imunitu (HIV), v\u00e4\u010d\u0161ina z nich v subsaharskej Afrike. Aj ke\u010f dosia\u013e nie je zn\u00e1my \u017eiadny liek na lie\u010dbu HIV\/AIDS, ich kombin\u00e1cia, zn\u00e1ma ako antiretrovir\u00e1lna terapia (ARV), umo\u017e\u0148uje pacientom \u017ei\u0165 dlh\u0161\u00ed a zdrav\u0161\u00ed \u017eivot.<\/strong><\/p>\n<\/div><\/div>\n\n

\n

V\u00edrus HIV sa pren\u00e1\u0161a krvou a telesn\u00fdmi tekutinami a postupne oslabuje imunitn\u00fd syst\u00e9m \u2013 obvykle behom troj- a\u017e desa\u0165ro\u010dn\u00e9ho obdobia, \u010do vedie k syndr\u00f3mu z\u00edskan\u00e9ho zlyhan\u00edm imunity \u2013 AIDS. S t\u00fdm, ako sa imunitn\u00fd syst\u00e9m oslabuje, sa m\u00f4\u017ee vyvin\u00fa\u0165 mno\u017estvo \u010fal\u0161\u00edch infekci\u00ed. Najbe\u017enej\u0161ia z nich je tuberkul\u00f3za, ktor\u00e1 vedie \u010dasto k \u00famrtiu.<\/p>\n<\/div><\/div>\n\n

\n

N\u00e1klady na lieky s\u00fa teraz lacnej\u0161ie ne\u017e kedykoLvek predt\u00fdm. Je ale st\u00e1le potrebn\u00e9 vynalo\u017ei\u0165 \u00fasilie na kvalitn\u00fa lie\u010dbu, ktor\u00e1 nakazen\u00fdm umo\u017en\u00ed \u017ei\u0165 dlh\u0161\u00ed a zdrav\u0161\u00ed \u017eivot.<\/strong><\/p>\n<\/div><\/div>\n\n

\n

MAGNA u\u017e od roku 2002 poskytuje starostlivos\u0165 pacientom \u017eij\u00facim s v\u00edrusom HIV\/AIDS. Boli sme jedni z prv\u00fdch, kto za\u010dal pod\u00e1va\u0165 detsk\u00fdm pacientom v Kambod\u017ei \u017eivot zachra\u0148uj\u00facu ARV lie\u010dbu. N\u00e1sledne sme na\u0161e HIV\/AIDS programy roz\u0161\u00edrili do Vietnamu, Kene, na Haiti a do Nikaraguy.<\/p>\n<\/div><\/div>\n\n

\n \"\"\n
KAMBOD\u017dA. Copyright Martin Band\u017e\u00e1k\/MAGNA<\/div>\n<\/div>\n\n
\n

Viac ako 90 % det\u00ed \u017eij\u00facich s virusom HIV sa nakazilo od svojej matky.<\/h2>\n<\/div><\/div>\n\n
\n

Pr\u00edtomnos\u0165 v\u00edrusu HIV m\u00f4\u017ee potvrdi\u0165 jednoduch\u00fd krvn\u00fd test, aj napriek tomu \u017eije mnoho \u013eud\u00ed roky bez pr\u00edznakov a v\u00f4bec nevie o tom, \u017ee boli infikovan\u00ed. Na celom svete je v s\u00fa\u010dasnosti asi 30 % \u013eud\u00ed, ktor\u00ed s\u00fa nakazen\u00ed v\u00edrusom HIV, ale nie s\u00fa si toho vedom\u00ed. V pr\u00edpade, \u017ee je pacientovi diagnostikovan\u00e1 t\u00e1to choroba, je pre zaistenie funguj\u00facej a efekt\u00edvnej lie\u010dby nevyhnutn\u00e9 monitorovanie v\u00edrusovej z\u00e1\u0165a\u017ee a meranie hladiny v\u00edrusu HIV v krvi. Zatia\u013e \u010do testy v\u00edrusovej z\u00e1\u0165a\u017ee s\u00fa v bohat\u00fdch krajin\u00e1ch rutinou, v rozvojov\u00fdch krajin\u00e1ch pr\u00edstup k n\u00edm st\u00e1le zaost\u00e1va.<\/p>\n<\/div><\/div>\n\n

\n

Lie\u010dba<\/strong><\/h3>\n<\/div><\/div>\n\n
\n

Kombin\u00e1cia liekov zn\u00e1mych ako antiretrovir\u00e1lne (ARV) pom\u00e1ha s v\u00edrusom bojova\u0165, redukova\u0165 \u0161\u00edrenie infekcie a umo\u017e\u0148uje pacientom \u017ei\u0165 dlh\u0161\u00ed a zdrav\u0161\u00ed \u017eivot bez r\u00fdchleho zhor\u0161ovania stavu imunitn\u00e9ho syst\u00e9mu. Deti \u017eij\u00face s AIDS s\u00fa jednou z najv\u00e4\u010d\u0161\u00edch trag\u00e9di\u00ed a v\u00fdziev v boji o kontrolu nad touto chorobou. WHO odhadovala, \u017ee v roku 2006 \u017eilo 2,5 mili\u00f3na det\u00ed do 15 rokov s HIV\/AIDS, pri\u010dom ka\u017ed\u00fd de\u0148 bolo infikovan\u00fdch \u010fal\u0161\u00edch 1200 det\u00ed. Bez lie\u010dby umiera polovica t\u00fdchto det\u00ed e\u0161te pred svojimi druh\u00fdmi narodeninami.<\/p>\n<\/div><\/div>\n\n

\n

Prevencia prenosu z matky na die\u0165a (PMTCT)<\/strong><\/h3>\n<\/div><\/div>\n\n
\n

Viac ako 90 % det\u00ed \u017eij\u00facich s virusom HIV sa nakazilo od svojej matky v priebehu tehotenstva, p\u00f4rodu alebo kojenia. Prevencia prenosu v\u00edrusu z matky na die\u0165a (PMTCT) m\u00f4\u017ee zn\u00ed\u017ei\u0165 pravdepodobnos\u0165 prenosu na menej ne\u017e dve percent\u00e1. MAGNA PMTCT integruje do starostlivosti o matku a die\u0165a, \u010do zahr\u0148uje testovanie a poskytovanie antiretrovir\u00e1lnych liekov (ARV) HIV pozit\u00edvnym tehotn\u00fdm \u017een\u00e1m, \u010falej poradenstvo o kojen\u00ed a prevent\u00edvne pod\u00e1vanie ARV novorodencom.<\/p>\n<\/div><\/div>\n\n

\n

Psychosoci\u00e1lna podpora<\/strong><\/h3>\n<\/div><\/div>\n\n
\n

Starostlivos\u0165 o du\u0161evn\u00e9 zdravie je integr\u00e1lnou s\u00fa\u010das\u0165ou programov MAGNA zameran\u00fdch na lie\u010dbu HIV \/ AIDS. V\u0161etci pacienti, ktor\u00ed dost\u00e1vaj\u00fa ARV lie\u010dbu na klinik\u00e1ch a v nemocniciach MAGNA maj\u00fa pr\u00edstup k psychosoci\u00e1lnej podpore.<\/p>\n<\/div><\/div>\n\n

\n
\n
\n

Lie\u010dime v\u010faka V\u00e1m<\/h3>\n
Va\u0161a podpora zohr\u00e1va v\u00fdznamn\u00fa \u00falohu v na\u0161ej pr\u00e1ci na z\u00e1chranu \u017eivotov.<\/div>\n <\/div>\n
\n <\/div>\n <\/div>\n<\/div>\n\n
\n
\n
\n

Viac o HIV\/AIDS v na\u0161ich projektoch<\/h2>\n
\n

Pre\u010d\u00edtajte si najnov\u0161ie \u010dl\u00e1nky o na\u0161ich zdravotn\u00fdch aktivit\u00e1ch.<\/p>\n <\/div>\n

\n V\u0161etky zdravotn\u00e9 aktivity<\/a>\n <\/div>\n
\n